Trials / Completed
CompletedNCT00747253
Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain Tumors
AutoLITT™ FIM Trial - A Prospective First-In-Man (FIM) Safety Trial of the AutoLITT Laser Treatment of Recurrent/Progressive Brain Tumors
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Monteris Medical · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of this study is to evaluate the safety and performance of the AutoLITT system for the treatment of recurrent/progressive glioblastoma multiforme tumors (GBM).
Conditions
- Brain Tumor
- Brain Tumor, Recurrent
- Brain Neoplasm
- Brain Cancer
- Glioblastoma Multiforme
- Recurrent Glioblastoma Multiforme
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | AutoLITT system | laser treatment with the AutoLITT system |
Timeline
- Start date
- 2008-08-01
- Primary completion
- 2009-10-01
- Completion
- 2010-04-01
- First posted
- 2008-09-05
- Last updated
- 2021-08-24
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00747253. Inclusion in this directory is not an endorsement.